Vatter P, Stoesser C, Samel I, Gierschik P, Moepps B. The variable C-terminal extension of G-protein-coupled receptor kinase 6 constitutes an accessorial autoregulatory domain. Ushiyama M, Ikeda R, Yoshida M, Mori K, Kangawa K, Sugawara H, Inoue K, Yamada K, Miyata A. Alternative splicing of the pituitary adenylate cyclase-activating polypetide receptor contributes to function of PACAP-27.

Tanowitz M, Hislop JN, von Zastrow M. Alternative splicing determines the post-endocytic sorting fate of G-protein-coupled receptors. Tang X, Tian Z, Chueh PJ, Chen S, Morre DM, Morre DJ. Alternative splicing as the premise for specific localization of tNOX, a novel hydroquinone oxidase, to the cancer cell surface.

Urano Y, Iiduka M, Sugiyama A, Akiyama H, Uzawa K, Matsumoto G, Kawasaki Y, Tashiro F. Involvement of the mouse Prp19 gene in neuronal/astroglial cell fate choices. Thomas CP, Raikwar NS, Kelley EA, Liu KZ. Alternate processing of Flt1 transcripts is directed by conserved cis-components inside an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation.

Tan D, Walker AM. Short type 1b human prolactin receptor down-regulates expression of the lengthy form. Sundvall M, Peri L, Maatta JA, Tvorogov D, Paatero I, Savisalo M, Silvennoinen O, Yarden Y, Elenius K. Differential nuclear localization and kinase exercise of different ErbB4 intracellular domains. Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, Wu Y, Lee V, Slingerland J, Dumont D, Yang BB. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis.

Vendelin J, Pulkkinen V, Rehn M, Pirskanen A, Raisanen-Sokolowski A, Laitinen A, Laitinen LA, Kere J, Laitinen T. Characterization of GPRA, a novel G protein-coupled receptor related to bronchial asthma. Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S. Implication of different splice transcripts of caspase-three and survivin in chemoresistance. Vegran F, Boidot R, Oudin C, Riedinger JM, Bonnetain F, Lizard-Nacol S. Overexpression of caspase-3s splice variant in regionally superior breast carcinoma is related to poor response to neoadjuvant chemotherapy.